Morphological and functional parameters in X-linked retinoschisis patients-A multicentre retrospective cohort study

被引:3
作者
Kiraly, Peter [1 ,2 ]
Seitz, Immanuel P. [3 ]
Abdalla Elsayed, Maram E. A. [1 ]
Downes, Susan M. [1 ,2 ]
Patel, Chetan K. [1 ]
Charbel Issa, Peter [1 ,2 ]
Birtel, Johannes [1 ,2 ,4 ,5 ]
Mautone, Luca [4 ]
Dulz, Simon [4 ]
Atiskova, Yevgeniya [4 ]
Herrmann, Philipp [5 ]
Vrabic, Nika [6 ]
Jarc-Vidmar, Martina [6 ]
Hawlina, Marko [6 ]
Fischer, M. Dominik [1 ,2 ,3 ]
机构
[1] Oxford Univ Hosp NHS Fdn Trust, Oxford Eye Hosp, Oxford, England
[2] Univ Oxford, Nuffield Lab Ophthalmol, Oxford, England
[3] Univ Hosp Tubingen, Ctr Ophthalmol, Tubingen, Germany
[4] Univ Med Ctr Hamburg Eppendorf, Dept Ophthalmol, Hamburg, Germany
[5] Univ Hosp Bonn, Dept Ophthalmol, Bonn, Germany
[6] Univ Med Ctr Ljubljana, Eye Hosp, Ljubljana, Slovenia
关键词
X-linked retinoschisis; XLRS; morphological parameters; functional parameters; symmetry between eyes; carbonic anhydrase inhibitors; gene therapy; trial endpoints; OPTICAL COHERENCE TOMOGRAPHY; CYSTIC MACULAR LESIONS; GENE-THERAPY; INTRAVITREAL DELIVERY; VISUAL-ACUITY; OUTCOMES; DORZOLAMIDE; DYSTROPHIES; THICKNESS; SYMMETRY;
D O I
10.3389/fmed.2023.1331889
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: X-linked retinoschisis (XLRS) is a potential target for gene supplementation approaches. To establish potential structural and functional endpoints for clinical trials, a comprehensive understanding of the inter-eye symmetry, relationship between structural and functional parameters, and disease progression is vital.Methods: In this retrospective multicentre study, 118 eyes of 59 XLRS patients with RS1 mutations were assessed. Information from center databases included: RS1 variant; age at presentation; best-corrected visual acuity (BCVA), central retinal thickness (CRT), macular volume (MV) at presentation and at the last follow up; full-field electroretinogram (ERG) findings; presence of peripheral retinoschisis and complications (vitreous hemorrhage, retinal detachment); treatment with systemic or topical carbonic anhydrase inhibitors (CAI).Results: Inter-eye symmetry revealed strong correlation in CRT (r = 0.77; p < 0.0001) and moderate correlations in MV (r = 0.51, p < 0.0001) and BCVA (r = 0.49; p < 0.0001). Weak or no correlations were observed between BCVA and structural parameters (CRT, MV). Peripheral retinoschisis was observed in 40 (68%), retinal detachment in 9 (15%), and vitreous hemorrhage in 5 (8%) patients, respectively. Longitudinal examinations (mean, 4.3 years) showed no BCVA changes; however, a reduction of the CRT (p = 0.02), and MV (p = 0.01) was observed. Oral and/or topical CAI treatment did not significantly alter the CRT (p = 0.34).Discussion: The XLRS phenotype demonstrates a strong CRT symmetry between the eyes within individual patients and stable BCVA over several years. BCVA exhibits a weak correlation with the morphological parameters of retinal thickness (CRT MV). In our cohort, longitudinal functional changes were not significant, likely attributed to the short average follow-up period. Furthermore, CAI treatment didn't influence both morphological and functional outcomes.
引用
收藏
页数:11
相关论文
共 50 条
[1]   Carbonic anhydrase inhibition in X-linked retinoschisis: An eye on the photoreceptors [J].
Ambrosio, Lucia ;
Williams, Jacqueline S. ;
Gutierrez, Alfredo ;
Swanson, Emily A. ;
Munro, Robert J. ;
Ferguson, R. Daniel ;
Fulton, Anne B. ;
Akula, James D. .
EXPERIMENTAL EYE RESEARCH, 2021, 202
[2]   Optical Coherence Tomography Retinal Thickness and Volume Measurements in X-Linked Retinoschisis [J].
Andreoli, Michael T. ;
Lim, Jennifer I. .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2014, 158 (03) :567-573
[3]   Use of dorzolamide for patients with X-linked retinoschisis [J].
Apushkin, Marsha A. ;
Fishman, Gerald A. .
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2006, 26 (07) :741-745
[4]   High Symmetry of Visual Acuity and Visual Fields in RPGR-Linked Retinitis Pigmentosa [J].
Bellingrath, Julia-Sophia ;
Ochakovski, G. Alex ;
Seitz, Immanuel P. ;
Kohl, Susanne ;
Zrenner, Eberhart ;
Hanig, Nicola ;
Prokisch, Holger ;
Weber, Bernhard H. ;
Downes, Susan M. ;
Ramsden, Simon ;
MacLaren, Robert E. ;
Fischer, M. Dominik .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (11) :4457-4466
[5]   Taking Stock of Retinal Gene Therapy: Looking Back and Moving Forward [J].
Bennett, Jean .
MOLECULAR THERAPY, 2017, 25 (05) :1076-1094
[6]   Diagnosis of Inherited Retinal Diseases [J].
Birtel, Johannes ;
Yusuf, Imran H. ;
Priglinger, Claudia ;
Rudolph, Guenter ;
Issa, Peter Charbel .
KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 2021, 238 (03) :249-259
[7]   Clinical and genetic characteristics of 251 consecutive patients with macular and cone/cone-rod dystrophy [J].
Birtel, Johannes ;
Eisenberger, Tobias ;
Gliem, Martin ;
Mueller, Philipp L. ;
Herrmann, Philipp ;
Betz, Christian ;
Zahnleiter, Diana ;
Neuhaus, Christine ;
Lenzner, Steffen ;
Holz, Frank G. ;
Mangold, Elisabeth ;
Bolz, Hanno J. ;
Issa, Peter Charbel .
SCIENTIFIC REPORTS, 2018, 8
[8]   Update on Viral Gene Therapy Clinical Trials for Retinal Diseases [J].
Cheng, Shun-Yun ;
Punzo, Claudio .
HUMAN GENE THERAPY, 2022, 33 (17-18) :865-878
[9]  
Couto L., 2022, Investig. Ophthalmol. Vis. Sci., V63, P2825
[10]   Retinal AAV8-RS1 Gene Therapy for X-Linked Retinoschisis: Initial Findings from a Phase I/IIa Trial by Intravitreal Delivery [J].
Cukras, Catherine ;
Wiley, Henry E. ;
Jeffrey, Brett G. ;
Sen, H. Nida ;
Turriff, Amy ;
Zeng, Yong ;
Vijayasarathy, Camasamudram ;
Marangoni, Dario ;
Ziccardi, Lucia ;
Kjellstrom, Sten ;
Park, Tae Kwon ;
Hiriyanna, Suja ;
Wright, J. Fraser ;
Colosi, Peter ;
Wu, Zhijian ;
Bush, Ronald A. ;
Wei, Lisa L. ;
Sieving, Paul A. .
MOLECULAR THERAPY, 2018, 26 (09) :2282-2294